BLCO · Bausch & Lomb Corp · Executive Compensation

$17.25 -0.30 (-1.71%) At close · Sep 11

Market Cap

$6.16B

357.17M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Brenton L. Saunders	Chairman of the Board and Chief Executive Officer	$1,600,000	—	$23,778,578	$2,799,998	$4,000,000	$15,750	$32,194,326
Sam Eldessouky	Executive Vice President and Chief Financial Officer	$777,981	$250,000	$2,514,714	$659,996	$744,000	$15,750	$4,962,441
A. Robert D. Bailey	Executive Vice President and Chief Legal Officer	$767,942	—	$1,714,561	$449,998	$673,200	$27,250	$3,632,951
Yehia Hashad	Executive Vice President of Research & Development and Chief Medical Officer	$726,116	—	$1,066,839	$279,996	$700,800	$15,750	$2,789,501
Andrew Stewart	President, Global Pharmaceuticals and International Consumer	$629,077	—	$990,631	$259,995	$604,800	$15,750	$2,500,253

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Brenton L. Saunders	Chairman of the Board and Chief Executive Officer	$1,600,000	—	$16,106,834	$2,799,997	$3,338,400	$15,525	$23,860,756
Sam Eldessouky	Executive Vice President and Chief Financial Officer	$766,885	—	$4,479,329	$750,000	$829,250	$15,525	$6,840,989
A. Robert D. Bailey	Executive Vice President and Chief Legal Officer	$767,423	—	$3,558,049	$500,000	$687,582	$15,525	$5,528,579
Yehia Hashad	Executive Vice President of Research & Development and Chief Medical Officer	$696,846	—	$2,867,061	$312,499	$629,160	$20,525	$4,526,091
Dr. Yehia Hashad	Executive Vice President of Research & Development and Chief Medical Officer	$696,846	—	$2,867,061	$312,499	$629,160	$20,525	$4,526,091
Andrew Stewart	President, Global Pharmaceuticals and International Consumer	$616,269	—	$2,636,714	$250,000	$552,762	$26,525	$4,082,270

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Brenton L. Saunders	Chairman of the Board and Chief Executive Officer	$1,396,923	$6,500,000	$27,870,000	$7,305,493	$2,181,436	$55,199	$45,309,051
A. Robert D. Bailey	Executive Vice President and Chief Legal Officer	$519,231	$200,000	$2,049,705	$1,999,997	$430,816	$14,850	$5,214,599
Sam Eldessouky	Executive Vice President and Chief Financial Officer	$710,769	—	$2,687,500	$749,999	$594,048	$14,850	$4,757,166
Dr. Yehia Hashad	Executive Vice President of Research & Development and Chief Medical Officer	$660,000	—	$1,119,765	$312,500	$551,616	$13,613	$2,657,494
Yehia Hashad	Executive Vice President of Research & Development and Chief Medical Officer	$660,000	—	$1,119,765	$312,500	$551,616	$13,613	$2,657,494
Andrew Stewart	President, Global Pharmaceuticals and International Consumer	$415,385	$600,000	$563,882	—	$344,653	$9,346	$1,933,266

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Papa	Chief Executive Officer	$1,600,000	—	$8,499,996	$8,499,996	$1,128,000	$53,769	$19,781,761
Sam Eldessouky	Executive Vice President and Chief Financial Officer	$700,000	—	$2,813,150	$2,249,998	$375,200	$13,725	$6,152,073
Christina M. Ackermann	Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals	$750,000	—	$2,063,144	$1,499,999	$402,000	$20,383	$4,735,526
Joseph F. Gordon	President, Global Consumer, Surgical and Vision Care	$600,000	—	$1,813,142	$1,249,999	$321,600	$13,882	$3,998,623
Joseph Gordon	—	$600,000	—	$1,813,142	$1,249,999	$321,600	$13,882	$3,998,623
Dr. Yehia Hashad	Executive Vice President of Research & Development and Chief Medical Officer	$602,500	—	$1,188,146	$624,997	$319,764	$117,386	$2,852,793

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Papa	Chief Executive Officer	$1,600,000	—	$16,561,105	$2,250,054	$2,448,000	$29,978	$22,889,137
Christina M. Ackermann	Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals	$750,000	—	$2,348,225	$600,033	$862,000	$14,330	$4,574,588
Sam Eldessouky	Executive Vice President & Chief Financial Officer	$620,385	—	$1,778,793	$1,187,756	$731,950	$13,340	$4,332,224
Joseph F. Gordon	President, Global Consumer, Surgical and Vision Care	$600,000	—	$1,507,810	$375,066	$739,600	$18,050	$3,240,526
Joseph Gordon	—	$600,000	—	$1,507,810	$375,066	$739,600	$18,050	$3,240,526

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Papa	Chief Executive Officer	$1,526,539	—	$8,127,907	$2,251,352	$2,160,000	$53,563	$14,119,361
Christina M. Ackermann	Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals	$743,654	—	$1,692,387	$540,362	$540,000	$24,625	$3,541,028
Joseph F. Gordon	President, Global Consumer, Surgical and Vision Care	$597,346	—	$785,420	$375,263	$432,000	$17,825	$2,207,854
Joseph Gordon	—	$597,346	—	$785,420	$375,263	$432,000	$17,825	$2,207,854
Sam Eldessouky	Executive Vice President & Chief Financial Officer	$500,000	—	$392,709	$187,631	$225,000	$12,825	$1,318,165

Executive changes

Person	Role	Change	Effective	Filed
Andrew C. von Eschenbach, M.D.	Board	Resigned	2026-08-05	2026-08-06
Steven H. Collis	Board	Resigned	2026-08-05	2026-08-06
Karen L. Ling	Board	Resigned	2026-08-05	2026-08-06
Thomas W. Ross, Sr.	Board	Resigned	2026-08-05	2026-08-06
Laurence Paul, M.D.	board of directors	Appointed	2026-08-05	2026-08-06
Barbara Trebbi	board of directors	Appointed	2026-08-05	2026-08-06
Robert Chersi	board of directors	Appointed	2026-08-05	2026-08-06
Thomas J. Appio	board of directors	Appointed	2026-08-05	2026-08-06
Steven H. Collis	board of directors	Appointed	2026-01-01	2025-12-17
Eduardo C. Alfonso	board of directors	Appointed	2026-01-01	2025-12-17
Gary Hu	board of directors	Resigned	2025-08-14	2025-08-18
Brett Icahn	board of directors	Resigned	2025-08-14	2025-08-18

Key facts CIK 1860742 CUSIP 071705107 13F (30d) 60 filings 60 filers Visit website Investor relations